Specifics of corticosteroid administration in patients with central nervous system diseases with a focus on neurointensive care
Klinická farmakologie a farmacie · 01.07.2026 · 40 (2) · 124-128
DOI: 10.36290/far.2026.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 01.07.2026. Verfasst von Lucie Sauerová. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kortikosteroidy hraj klovou roli v rmci terapie onkologickch, infeknch i autoimunitnch onemocnn centrln nervov soustavy. Redukuj zntliv procesy, jsou pouvny zejmna ke zmrnn edmu mozku a intrakranilnho tlaku, m vznamn zlepuj kvalitu ivota pacient. V rmci funknho deficitu hypofzy i hypothalamu se podvaj tak jako substitun lba. Podvn nen indikovno plon u vech pacient. Ped nasazenm by se ml zhodnotit risk/benefit, tedy zvanost klinickch projev onemocnn a riziko nedoucch ink, u infeknch onemocnn tak pvodce. lnek je zamen na podvn kortikosteroid v neurointenzivn pi a u pacient s infekcemi centrln nervov soustavy. Nezabv se lbou onkologickch a autoimunitnch onemocnn.
Zitieren
APA
Sauerová, L. (2026). Specifics of corticosteroid administration in patients with central nervous system diseases with a focus on neurointensive care. Klinická farmakologie a farmacie, 40(2), 124-128. https://doi.org/10.36290/far.2026.008
Vancouver
Sauerová L. Specifics of corticosteroid administration in patients with central nervous system diseases with a focus on neurointensive care. Klinická farmakologie a farmacie. 2026;40(2):124-128. doi:10.36290/far.2026.008
BibTeX
@article{Sauerov2026,
author = {Sauerová, Lucie},
title = {Specifics of corticosteroid administration in patients with central nervous system diseases with a focus on neurointensive care},
journal = {Klinická farmakologie a farmacie},
year = {2026},
volume = {40},
number = {2},
pages = {124--128},
doi = {10.36290/far.2026.008}
}
EUVIMED